Results 141 to 150 of about 16,960 (244)

Efficacy of 4 Weeks Therapy with Eplerenone in Resistant Hypertension: Reduction of Aortic Blood Pressure, Arterial Stiffness, and Impact on IL-6 Levels

Artery Research
Background Resistant hypertension affects 10–15% of treated patients and remains a therapeutic challenge. Eplerenone is recommended when spironolactone is ineffective or poorly tolerated.
Stanisław Wasiliew, Dawid Lipski, Łukasz Stryczyński, Artur Radziemski, Jan Królak, Andrzej Tykarski, Paweł Uruski   +6 more
doaj   +1 more source

Eplerenone [PDF]

, 2020
openaire   +1 more source

Proteomic Profile After Intervention With Eplerenone Among Persons With HIV. [PDF]

Open Forum Infect Dis
Murthy A, Kolossváry M, Walpert AR, Sanchez E, Abohashem S, Tawakol A, Adler GK, Grinspoon SK, Srinivasa S.   +8 more
europepmc   +1 more source

The novel mineralocorticoid receptor modulator balcinrenone protects against diet-induced cardiac microvascular dysfunction and plasma potassium elevation in mouse models. [PDF]

PLoS One
Wolf MJ, El Moghrabi S, Palacios-Ramirez R, Bamberg K, Bradley LA, Epstein FH, Hartleib-Geschwindner J, Jaisser F.   +7 more
europepmc   +1 more source

Eplerenone lowers maternal blood pressure in a model of leptin-induced preeclampsia, but decreases fetal growth when administered mid-, but not late-, gestation. [PDF]

Am J Physiol Heart Circ Physiol
Mellott E, Moronge D, Cooper G, Backer K, Connor G, Elgazzaz M, Ogbi S, Faulkner JL.   +7 more
europepmc   +1 more source

Dissecting the role of mineralocorticoid receptors in binge-like alcohol drinking in mice: Finerenone as a potential pharmacotherapy. [PDF]

Psychopharmacology (Berl)
Wilkinson CS, Bruns N, Pince CL, McGinn MA, Farokhnia M, Leggio L, Vendruscolo LF.   +6 more
europepmc   +1 more source

Comparative safety profiles of spironolactone, eplerenone, and finerenone: a pharmacovigilance study based on FAERS data from 2004 to 2024. [PDF]

Front Pharmacol
Ji K, Huang X, Wang F, Zhang L, Zheng Y, Ji L, Ju Y, Zhuang X, Li J.   +8 more
europepmc   +1 more source

Selective and nonselective mineralocorticoid receptor antagonists in central serous chorioretinopathy: systematic review and meta-analysis. [PDF]

BMC Ophthalmol
Park JY, Jang Y, Hahn S.
europepmc   +1 more source

Drug-Resistant Sinus Tachycardia as a Dose-Dependent Side Effect of Spironolactone: A Case Report and Review of the Literature. [PDF]

Clin Case Rep
Abdi Z, Chenaghlou M, Rezabakhsh A, Hooshmand Gharabagh L.   +3 more
europepmc   +1 more source

Mineralocorticoid Antagonists as Adjuncts in Neovascular Age-Related Macular Degeneration [PDF]

, 2016

core   +1 more source